The compound Zilmax (Zilpaterol hydrochloride) is commonly used across conditions characterized by periods of heightened symptoms (in this context, physiological efforts related to maximizing weight gain), specifically in cattle fed in confinement for slaughter during the final weeks of the feeding period. Zilmax is commonly used to support production goals, which include addressing conditions associated with suboptimal feed efficiency, low carcass leanness, and non-optimized rate of weight gain in finishing cattle. This therapeutic area helps address groups of symptoms that may become disruptive to optimal production goals.

This application contributes to easing the physiological strain during this final period, which supports general well-being and the desired progression toward lean tissue development. The benefit assists with maintaining functional stability and production targets, including supporting the desired parameters for hot carcass weight and overall feedlot performance. This approach may be part of symptomatic management during phases when maximizing growth potential is paramount.

Quick Fact: Relief for Suboptimal Nutrient Conversion

Regulatory References

1. U.S. Food and Drug Administration Freedom of Information Summary, NADA 141-258

Eligibility Map: Who Can and Cannot Use Zilmax — Official Regulatory Information

The eligibility profile for Zilmax (Zilpaterol hydrochloride) is strictly defined by its designation as an animal drug and its purpose in livestock management. Official regulatory documents establish clear restrictions on which populations can and cannot use the product.

Eligibility is limited solely to cattle fed in confinement for slaughter. This use is restricted to a defined period, specifically the last 20 to 40 days on feed. Furthermore, a mandatory 3-day withdrawal period must be observed immediately before the cattle are sent to harvest. The product must also not be administered if the cattle's feed consumption exceeds specified regulatory limits.

Interactions with other medicines and products

The official interaction profile for Zilmax (Zilpaterol hydrochloride) is defined by mandatory co-administration approvals and restrictions based on its pharmacological class as a beta2-adrenergic agonist, according to government regulatory documentation.

Official Interaction Structure

Pharmacokinetic and Timing Rules

Official government prescribing information does not document specific interactions related to major metabolic pathways, such as Cytochrome P450 (CYP) enzymes or specific drug transporters. Additionally, no mandatory dose timing separation rules are required for the co-administered drugs, as the combination agents are intended for continuous, concurrent delivery within a single medicated feed ration.

Zilmax is a beta-adrenergic agonist that selectively binds to beta-2 receptors expressed on muscle cells. This ligand-receptor interaction initiates signal transduction by modulating adenylyl cyclase activity, which increases intracellular concentrations of cyclic adenosine monophosphate (cAMP). The elevated cAMP subsequently alters the transcriptional and translational rate of lean muscle protein synthesis. Activation of the receptor stimulates downstream signaling, including protein kinase A (PKA) activation. This cascade leads to the phosphorylation of specific intracellular targets, influencing the rate of protein turnover and impacting muscle fiber structure. This modulation of both protein catabolism and anabolism acts to influence the overall composition of muscle mass.

Zilpaterol hydrochloride, marketed as Zilmax, is administered strictly through the oral route, being incorporated directly into the animal's total feed ration. The compound is supplied as a Type A Medicated Article, a highly concentrated powder that must be thoroughly diluted and mixed before use; feeding the concentrated article undiluted is prohibited. This preparation ensures the uniform delivery of a specified daily intake.

The standard specified dosing involves administration to provide 60 to 90 mg of the compound per head per day. This compound is administered on a continuous basis as the sole ration during the final stages of the feeding process. The designated treatment duration is defined as the last 20 to 40 days on feed for cattle confined for slaughter.

Instructions for use provide high-level rules for specific populations and handling. Use is restricted solely to finishing cattle and is explicitly prohibited in animals intended for breeding or in veal calves. Furthermore, special handling constraints apply, such as the prohibition against pelleting medicated feed containing the compound. Following the final administration, a mandatory 3-day withdrawal period from the medicated feed must be strictly observed prior to the animal’s transport for slaughter. The entire usage protocol is therefore structured as a time-limited intervention with specific preparation and cessation requirements.

Research Evidence / Overview of Studies for Zilmax

The research landscape for Zilpaterol hydrochloride (Zilmax) is primarily composed of Randomized Controlled Trials (RCTs), systematic reviews, and meta-analyses. These studies were conducted to examine the compound's association with the development of lean tissue and feed efficiency in its specific target population—cattle in the final weeks of feeding for slaughter. Research was designed to describe patterns related to performance and carcass measurements in these animals compared to control groups that did not receive the compound.

1. Evidence for Optimizing Performance and Tissue Development

Researchers primarily used short-term RCTs to study how Zilpaterol was associated with changes in growth and resource use. These studies measured outcomes related to feedlot performance, including Feed Efficiency (G:F ratio) and Average Daily Gain.

Across multiple trials, studies reported measurements related to a higher Hot Carcass Weight (HCW) in supplemented populations compared to controls. Research has also explored how Feed Efficiency was measured, noting patterns related to the consumed feed volume during the period the compound was administered.

2. Research on Carcass Composition and Meat Quality Parameters

Research was conducted to evaluate the compound’s relationship with the physical attributes of the carcass. This primarily involved measuring indicators of lean muscle development and carcass leanness. Researchers examined the Longissimus Muscle Area (LMA) (ribeye area) and fat thickness.

Studies reported consistent patterns across multiple trials concerning measurements related to a larger Longissimus Muscle Area (LMA) and a lower fat thickness in supplemented groups. Beyond these outcomes, researchers consistently studied the relationship between the compound's use and objective meat quality measures. Warner-Bratzler shear force—a scientific measure of firmness/tenderness—was measured as higher in some supplemented groups compared to controls.

5. What is Still Uncertain About Zilpaterol Research

Despite the availability of numerous RCTs and meta-analyses, some key research limitations and gaps have been noted. The follow-up durations were limited to the short administration period (20–40 days), meaning there is limited information for long-term outcomes and the durability of observed patterns is not fully established.

One area of uncertainty relates to the variability of certain outcomes, particularly those related to meat quality, where different patterns were observed across studies regarding firmness. The full role of variables such as pre-study diet and processing methods in the final measured outcomes is not fully established.

Key Studies & References U.S. Food and Drug Administration Freedom of Information Summary, NADA 141-258

How to Store and Dispose of Zilmax (Zilpaterol Hydrochloride)

The storage and disposal of Zilmax, a concentrated powder pre-mix, must adhere strictly to regulatory requirements to maintain product stability and ensure safety.

Storage Requirements

Safety and Disposal

The product must be kept out of reach of children and animals. Disposal of any unused product or waste material must be conducted in accordance with local or national regulations. It is prohibited to discard the product or containers where they could contaminate waterways, such as ponds, ditches, or rivers.